Feb 3, 2020
Alexander Frekey
1,96m 113kg / 6'5" 249lbs
seen from China
seen from Ukraine
seen from Saudi Arabia
seen from Malaysia
seen from United States
seen from Brazil
seen from United Kingdom
seen from Malaysia
seen from Sweden
seen from Australia
seen from China
seen from United States
seen from United Kingdom
seen from Saudi Arabia
seen from Brazil
seen from Russia
seen from United Kingdom
seen from United States
seen from Malaysia
seen from United States
Alexander Frekey
1,96m 113kg / 6'5" 249lbs
The Power of EPCS: Enhancing Prescription Accuracy and Compliance
What Is EPCS?
EPCS allows healthcare providers to electronically send prescriptions for controlled substances directly to pharmacies using secure, certified systems—replacing handwritten and paper-based methods.
Key components include:
Identity verification & two-factor authentication for prescribers.
Use of DEA-compliant, EPCS-certified software.
Digital prescription creation made stronger with audit trails and encryption.
Why it's a Game-Changer in 2025
1. Patient Safety & Accuracy
Eliminates handwriting misinterpretation and dosage errors.
Automated alerts flag dangerous drug, drug interactions, allergies, and duplications.
Access to full medication history helps prevent overprescribing and doctor-shopping.
2. Enhanced Security & Fraud Prevention
Electronic signing and transmission reduce the risk of forgery or tampering.
Controlled substance prescriptions are tracked electronically via DEA and state PDMP integrations.
A July 2023 DEA rule now permits one-time electronic transfer of CII–V prescriptions between pharmacies, provided it remains digital.
3. Stronger Compliance & Oversight
Meets federal mandates such as the SUPPORT Act (Medication prescribing under Medicare Part D).
State laws increasingly require electronic controlled substance prescriptions—e.g., California since 2022.
All electronic prescriptions include complete audit logs, enabling easier review during inspections.
4. Operational Efficiency
Faster processing—eliminates printing, faxing, and manual clarifications—beneficial for both providers and pharmacies.
Built-in formulary and real-time benefit tools help providers choose affordable medications covered by insurance.
Saves administrative time—one AMA-backed study showed up to 70% reduction in prescription-related tasks.
5. Improved Patient Experience
Eliminates lost prescriptions, reduces pharmacy wait times.
Enables seamless refill reminders and renewal requests electronically.
Parents of pediatric patients, for example, appreciate avoiding extra trips for ADHD medication refills.
Adoption & Industry Impact
EPCS adoption soared from 7% in 2008 to roughly 82% of prescribers by 2021, with most pharmacies now enabled.
The global e-prescribing market is projected to grow at 24–26% CAGR by 2029, driven by demand for better clinical integration and efficiency.
New technological trends like AI-driven clinical decision support, real-time benefit checks, and bi-directional data exchange between EHRs and pharmacies are enhancing functionality.
Final Takeaways
EPCS isn’t just a compliance checkbox—it’s a cornerstone of modern, safer, and more efficient care:
Protecting patients via clinical alerts, robust tracking, and floodgates against misuse
Streamlining provider workflows and cutting administrative waste
Enhancing transparency and compliance both federally and at state levels
Laying the groundwork for future innovations like AI, real-time benefits, and seamless EHR–pharmacy interaction
For healthcare providers, turning EPCS on is less of a leap than a critical step forward—one that supports better patient outcomes, fewer errors, and a future-ready practice.
17,455 Energy Performance Certificates for properties in England and Wales are withheld from public access
Post: 24 March 2024
New blog post on my website:
17,455 Energy Performance Certificates for properties in England and Wales are withheld from public access
Energy efficiency of housing in Parliamentary constituencies in England and Wales, 2023
Post: 23 November 2023
New blog post on my website:
Energy efficiency of housing in Parliamentary constituencies in England and Wales, 2023
ICO decision confirms Open Government Licence is insufficient for open re-use of Energy Performance of Buildings data
Post: 31 May 2023
New blog post on my website:
ICO decision confirms Open Government Licence is insufficient for open re-use of Energy Performance of Buildings data
0 notes
Energy efficiency of housing in Parliamentary constituencies in England and Wales, 2022
Post: 25 November 2022
New blog post on my website:
Energy efficiency of housing in Parliamentary constituencies in England and Wales, 2022
98% of domestic Energy Performance Certificates have been matched to UPRNs
Post: 16 September 2022
New blog post on my website:
98% of domestic Energy Performance Certificates have been matched to UPRNs